WeirFoulds represents Antibe Therapeutics in $8M public offering
On August 13, 2019, Antibe Therapeutics Inc. (“Antibe”) (TSXV: ATE) announced that it closed its previously announced public offering of units (the “Units”) raising aggregate gross proceeds…